Patent 11951181 was granted and assigned to Translate Bio on April, 2024 by the United States Patent and Trademark Office.
Disclosed herein are compositions and methods for modulating the production of a protein in a target cell. The compositions and methods disclosed herein are capable of ameliorating diseases associated with protein or enzyme deficiencies.